Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
China Jo-Jo Drugstores Inc Market Cap
From what 0 stock analysts predict, the share price for China Jo-Jo Drugstores Inc (CJJD) might decrease by 100% in the next year. This is based on a 12-month average estimation for CJJD. Price targets go from $ to $. The majority of stock analysts believe CJJD is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedCJJD 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect China Jo-Jo Drugstores Inc to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CJJD. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CJJD.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
2009
Staff Count
939
Country
China
Sector/Industry
Healthcare/Pharmaceutical Retailers
CEO
Mr. Lei Liu M.D.
Market Cap
$12.4M
In 2023, CJJD generated $148.8M in revenue, which was a decrease of -9.48% from the previous year. This can be seen as a signal that CJJD's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Tue, 30 Jul 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores, Inc. reported its fiscal year 2024 financial results, highlighting its strong performance in the pharmaceutical retail sector amid market changes.
Why It Matters - Strong financial results from China Jo-Jo Drugstores signal resilience and potential growth in the healthcare sector, making it a key player for investors looking at the Chinese market.
Tue, 11 Jun 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores, Inc. will issue 1,980,000 ordinary shares at $1.70 each, raising approximately $3.37 million in a registered direct offering, closing around June 26, 2024.
Why It Matters - China Jo-Jo Drugstores is raising $3.37 million through a direct share offering, potentially impacting stock dilution, liquidity, and investor sentiment while funding growth initiatives.
Fri, 31 May 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores, Inc. announced the resignation of board member Ms. Pingfan Wu, effective May 31, 2024, citing personal reasons.
Why It Matters - Board member resignations can signal instability or shifts in company strategy, potentially impacting investor confidence and stock performance.
Fri, 10 May 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores, Inc. will issue 1.61 million shares at $1.70 each, raising approximately $2.74 million in a registered direct offering, closing around May 17, 2024.
Why It Matters - China Jo-Jo Drugstores is raising $2.74 million through a direct share offering, potentially impacting its liquidity and growth strategies, which could influence investor sentiment and stock performance.
Mon, 29 Apr 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores, Inc. plans to issue 0.9 million ordinary shares at $1.70 each in a direct offering, aiming for gross proceeds of approximately $1.53 million, closing expected by April 30, 2024.
Why It Matters - China Jo-Jo Drugstores' direct offering raises $1.53 million, potentially diluting existing shares but providing capital for growth, impacting stock valuation and investor sentiment.
Tue, 19 Mar 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - China Jo-Jo Drugstores (NASDAQ: CJJD) has regained compliance with Nasdaq's minimum bid price requirement, closing the matter after previously being notified on June 15, 2023.
Why It Matters - China Jo-Jo Drugstores' compliance with Nasdaq's minimum bid price restores investor confidence, potentially stabilizing share prices and improving market perception.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
